Prepare to embark on an enlightening journey as we tap into the wealth of knowledge possessed by our esteemed bioinformatics experts, who will be sharing practical solutions to real-world challenges in variant analysis. Each installment of this webinar series will explore the strategies employed by the SOPHiA DDM™ Platform to effectively detect challenging variants associated with cancers and rare and inherited disorders.
In this session, we are excited to introduce you to Xiaobin Xing, Director of Bioinformatics, boasting over a decade of invaluable experience at SOPHiA GENETICS. Xiaobin will explain how signal amplification and noise suppression can increase the analytical performance of NGS applications. He will present examples of the strategies employed by SOPHiA DDM™ to accurately detect challenging variants important for specific applications from liquid biopsy to homologous recombination deficiency, and pharmacogenomics to RNA sequencing for fusion detection.
Multiple in-house algorithms are deployed in SOPHiA DDM™ to universally detect challenging variants with high accuracy regardless of sample type, DNA extraction technique, library preparation technology, or sequencing platform. Don’t miss this opportunity to uncover the secrets of our proprietary methodologies for detecting challenging variants. Tune in now!
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.